Immunohistochemistry (IHC) Market Size, Share & Trends Analysis By Product, By Application, By End-Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Global Immunohistochemistry Market is projected to be worth USD 5.8 billion by 2030
According to SPER Market Research, the Immunohistochemistry Market is estimated to reach USD 5.8 billion by 2030 with a CAGR of 6.5%. Increase in geriatric population, prevalence of infectious disease, advanced technology, increase in the funding, investment in research & development; these are the key to the expansion of this market.
Impact of COVID-19 on the Immunohistochemistry Market
The outbreak of COVID-19 increased the investment in research to find out more effective treatment for it, so big Pharma companies came into field.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Product, By Application, By End Users, By Region
Geographies covered
North America, Europe, Asia Pacific, Latin America , Middle East, Africa
Companies Covered
Abcam plc, Agilent Technologies, Inc., Becton, Bio SB, Inc., Biocare Medical, LLC, Biogenex Laboratories, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioVision Inc., CANDOR Bioscience GmbH, Cell Signalling Technology, Inc., Danaher Corporation, Diagnostic Biosystems, Inc., Dickinson and Company, Eagle Biosciences, Inc., Elabscience, Inc., F. Hoffman-La Roche AG, Genemed Biotechnologies, Inc.,Merck KGaA , Miltenyi Biotec, PerkinElmer, Inc., PHC Holdings Corporation, Rockland Immunochemicals, Inc., Sakura Finetek Japan Co., Ltd., Takara Bio, Inc., Thermo Fisher Scientific, Inc.
Driver: Geriatric population & prevalence of infectious disease
There is increase in the geriatric population in low, medium, high-income countries as well, the intense prevalence of chronic infectious disease globally; there by increasing the expansion of this market.
Restraints: Intense Consolidation
The Immunohistochemistry Market is highly consolidated with few market players, patent expiry, government pressure in terms of price, less outcome in research & development; are the restraints of this market.
Opportunity: choice for Personalized Medicine
The choices for personalized medicine have been increased, Immunohistochemistry helps in the personalization of medicines, and the low cost of Immunohistochemistry technique is the ideal for the treatment of cancer.
Challenges: Unskilled Professional
There is lack of skilled personnel in the laboratory, those who are there almost at the verge of retirement.
Global Immunohistochemistry Market, by Product:
Antibodies (Primary antibodies, Secondary antibodies), Reagents (Blocking Sera and Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Other Reagents, Proteolytic Enzymes), Equipment ( Slide Scanners, Slide-staining Systems, Tissue Processing Systems, Other Equipment ),
Kits (IHC Kits for Animal tissue, IHC Kits for Human tissue).
Global Immunohistochemistry Market, by Application:
Diagnostic applications (Autoimmune diseases, Cancer, Infectious diseases, Nephrological diseases, Neurological diseases, other diseases), Research applications (Drug development and Testing, stem cell research and developmental biology), Forensic applications.
Global Immunohistochemistry Market, by End-Users:
Academic & research Institutes, Hospitals & Diagnostic Laboratories, Other end users (CROs, Pharma & biopharma companies, and forensic laboratories)
Global Immunohistochemistry Market, by Region:
North America dominates the biggest share of the Immunohistochemistry Market; due to advanced economy, technological advancement, geriatric population, supportive reimbursement policies, effective government initiatives, investment on research & development.
Asia Pacific has top expansion in this market due to increase investment in healthcare infrastructure, rising disposal income, invest by big Pharma companies.
According to SPER Market Research, the Immunohistochemistry Market is estimated to reach USD 5.8 billion by 2030 with a CAGR of 6.5%. Increase in geriatric population, prevalence of infectious disease, advanced technology, increase in the funding, investment in research & development; these are the key to the expansion of this market.
Impact of COVID-19 on the Immunohistochemistry Market
The outbreak of COVID-19 increased the investment in research to find out more effective treatment for it, so big Pharma companies came into field.
Scope of the report:
Market size available for years
2019-2030
Base year considered
2021
Forecast period
2022-2030
Segments covered
By Product, By Application, By End Users, By Region
Geographies covered
North America, Europe, Asia Pacific, Latin America , Middle East, Africa
Companies Covered
Abcam plc, Agilent Technologies, Inc., Becton, Bio SB, Inc., Biocare Medical, LLC, Biogenex Laboratories, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioVision Inc., CANDOR Bioscience GmbH, Cell Signalling Technology, Inc., Danaher Corporation, Diagnostic Biosystems, Inc., Dickinson and Company, Eagle Biosciences, Inc., Elabscience, Inc., F. Hoffman-La Roche AG, Genemed Biotechnologies, Inc.,Merck KGaA , Miltenyi Biotec, PerkinElmer, Inc., PHC Holdings Corporation, Rockland Immunochemicals, Inc., Sakura Finetek Japan Co., Ltd., Takara Bio, Inc., Thermo Fisher Scientific, Inc.
Driver: Geriatric population & prevalence of infectious disease
There is increase in the geriatric population in low, medium, high-income countries as well, the intense prevalence of chronic infectious disease globally; there by increasing the expansion of this market.
Restraints: Intense Consolidation
The Immunohistochemistry Market is highly consolidated with few market players, patent expiry, government pressure in terms of price, less outcome in research & development; are the restraints of this market.
Opportunity: choice for Personalized Medicine
The choices for personalized medicine have been increased, Immunohistochemistry helps in the personalization of medicines, and the low cost of Immunohistochemistry technique is the ideal for the treatment of cancer.
Challenges: Unskilled Professional
There is lack of skilled personnel in the laboratory, those who are there almost at the verge of retirement.
Global Immunohistochemistry Market, by Product:
Antibodies (Primary antibodies, Secondary antibodies), Reagents (Blocking Sera and Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Other Reagents, Proteolytic Enzymes), Equipment ( Slide Scanners, Slide-staining Systems, Tissue Processing Systems, Other Equipment ),
Kits (IHC Kits for Animal tissue, IHC Kits for Human tissue).
Global Immunohistochemistry Market, by Application:
Diagnostic applications (Autoimmune diseases, Cancer, Infectious diseases, Nephrological diseases, Neurological diseases, other diseases), Research applications (Drug development and Testing, stem cell research and developmental biology), Forensic applications.
Global Immunohistochemistry Market, by End-Users:
Academic & research Institutes, Hospitals & Diagnostic Laboratories, Other end users (CROs, Pharma & biopharma companies, and forensic laboratories)
Global Immunohistochemistry Market, by Region:
North America dominates the biggest share of the Immunohistochemistry Market; due to advanced economy, technological advancement, geriatric population, supportive reimbursement policies, effective government initiatives, investment on research & development.
Asia Pacific has top expansion in this market due to increase investment in healthcare infrastructure, rising disposal income, invest by big Pharma companies.
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Immunohistochemistry Market
4.4. Market Trends
5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
5.1. Antibodies
5.1.1. Primary antibodies
5.1.2. Secondary antibodies
5.2. Reagents
5.2.1. Blocking Sera and Reagents
5.2.2. Chromogenic Substrates
5.2.3. Diluents
5.2.4. Fixation Reagents
5.2.5. Histological Stains
5.2.6. Organic Solvents
5.2.7. Other Reagents
5.2.8. Proteolytic Enzymes
5.3. Equipment
5.3.1. Slide Scanners
5.3.2. Slide-staining Systems
5.3.3. Tissue Processing Systems
5.3.4. Other Equipment
5.4. Kits
5.4.1. IHC Kits for Animal tissue
5.4.2. IHC Kits for Human tissue
6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Diagnostic applications
6.1.1. Autoimmune diseases
6.1.2. Cancer
6.1.3. Infectious diseases
6.1.4. Nephrological diseases
6.1.5. Neurological diseases
6.1.6. Other diseases (ophthalmic, cardiovascular, dermatological, and dental diseases)
6.2. Research applications
6.2.1. Drug development and Testing
6.2.2. Other research applications (stem cell research and developmental biology)
6.3. Forensic applications
7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END-USERS, 2019-2030 (USD MILLION)
7.1. Academic & research Institutes
7.2. Hospitals & Diagnostic Laboratories
7.3. Other end users (CROs, pharma & biopharma companies, and forensic laboratories)
8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2019-2030 (USD MILLION)
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. France
8.2.2. Germany
8.2.3. Italy
8.2.4. Spain
8.2.5. Rest of the Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Rest of Asia Pacific
8.4. Latin America
8.5. Middle East
8.6. Africa
9. COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. COMPANY PROFILES
10.1. Abcam plc
10.2. Agilent Technologies, Inc.
10.3. Becton
10.4. Bio SB, Inc.
10.5. Biocare Medical, LLC
10.6. Biogenex Laboratories
10.7. Bio-Rad Laboratories, Inc.
10.8. Bio-Techne Corporation
10.9. BioVision Inc.
10.10. CANDOR Bioscience GmbH
10.11. Cell Signalling Technology, Inc.
10.12. Danaher Corporation
10.13. Diagnostic Biosystems, Inc.
10.14. Dickinson and Company
10.15. Eagle Biosciences, Inc.
10.16. Elabscience, Inc.
10.17. F. Hoffman-La Roche AG
10.18. Genemed Biotechnologies, Inc.
10.19. Merck KGaA
10.20. Miltenyi Biotec
10.21. PerkinElmer, Inc.
10.22. PHC Holdings Corporation
10.23. Rockland Immunochemicals, Inc.
10.24. Sakura Finetek Japan Co., Ltd.
10.25. Takara Bio, Inc.
10.26. Thermo Fisher Scientific, Inc.
11. APPENDIX
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Immunohistochemistry Market
4.4. Market Trends
5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2030 (USD MILLION)
5.1. Antibodies
5.1.1. Primary antibodies
5.1.2. Secondary antibodies
5.2. Reagents
5.2.1. Blocking Sera and Reagents
5.2.2. Chromogenic Substrates
5.2.3. Diluents
5.2.4. Fixation Reagents
5.2.5. Histological Stains
5.2.6. Organic Solvents
5.2.7. Other Reagents
5.2.8. Proteolytic Enzymes
5.3. Equipment
5.3.1. Slide Scanners
5.3.2. Slide-staining Systems
5.3.3. Tissue Processing Systems
5.3.4. Other Equipment
5.4. Kits
5.4.1. IHC Kits for Animal tissue
5.4.2. IHC Kits for Human tissue
6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
6.1. Diagnostic applications
6.1.1. Autoimmune diseases
6.1.2. Cancer
6.1.3. Infectious diseases
6.1.4. Nephrological diseases
6.1.5. Neurological diseases
6.1.6. Other diseases (ophthalmic, cardiovascular, dermatological, and dental diseases)
6.2. Research applications
6.2.1. Drug development and Testing
6.2.2. Other research applications (stem cell research and developmental biology)
6.3. Forensic applications
7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END-USERS, 2019-2030 (USD MILLION)
7.1. Academic & research Institutes
7.2. Hospitals & Diagnostic Laboratories
7.3. Other end users (CROs, pharma & biopharma companies, and forensic laboratories)
8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2019-2030 (USD MILLION)
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. France
8.2.2. Germany
8.2.3. Italy
8.2.4. Spain
8.2.5. Rest of the Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. Rest of Asia Pacific
8.4. Latin America
8.5. Middle East
8.6. Africa
9. COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments
10. COMPANY PROFILES
10.1. Abcam plc
10.2. Agilent Technologies, Inc.
10.3. Becton
10.4. Bio SB, Inc.
10.5. Biocare Medical, LLC
10.6. Biogenex Laboratories
10.7. Bio-Rad Laboratories, Inc.
10.8. Bio-Techne Corporation
10.9. BioVision Inc.
10.10. CANDOR Bioscience GmbH
10.11. Cell Signalling Technology, Inc.
10.12. Danaher Corporation
10.13. Diagnostic Biosystems, Inc.
10.14. Dickinson and Company
10.15. Eagle Biosciences, Inc.
10.16. Elabscience, Inc.
10.17. F. Hoffman-La Roche AG
10.18. Genemed Biotechnologies, Inc.
10.19. Merck KGaA
10.20. Miltenyi Biotec
10.21. PerkinElmer, Inc.
10.22. PHC Holdings Corporation
10.23. Rockland Immunochemicals, Inc.
10.24. Sakura Finetek Japan Co., Ltd.
10.25. Takara Bio, Inc.
10.26. Thermo Fisher Scientific, Inc.
11. APPENDIX
